Literature DB >> 20819773

Expression of lumican in the articular disc of the human temporomandibular joint.

N Kiga1, I Tojyo, T Matsumoto, Y Hiraishi, Y Shinohara, S Fujita.   

Abstract

Lumican belongs to the small leucine-rich repeat proteoglycan (SLRP) gene family and has been reported to exist in the cornea, intervertebral disc and tendon. Lumican plays a significant role in the assembly and regulation of collagen fibres. The human temporomandibular joint (TMJ) disc is made up of fibrocartilage with an extracellular matrix (ECM) composed of collagen and proteoglycans. The existence and behaviour of lumican has not been studied in the human TMJ disc. Therefore, we used immunohistochemical methods to detect lumican, CD34 and vascular endothelial growth factor (VEGF) and histochemical staining with toluidine blue in 13 human TMJ specimens (10 surgically removed and 3 obtained from autopsy). In both the normal and the deformed discs we observed staining with toluidine blue. We found that the area of metachromasia inside the deformed disc was uneven and expression of lumican was strong in the areas negative for metachromasia. Staining of VEGF and CD34 inside the deformed disc was seen. We confirmed the expression of lumican in the human TMJ disc and showed that a large number of fibroblast-like cells existed in the area of strong lumican expression. These new findings about the behaviour of lumican suggest that it may play a key role in the generation of a new collagen network by fibroblast-like cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819773      PMCID: PMC3167310          DOI: 10.4081/ejh.2010.e34

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


Introduction

In 1988, Scott[1] reported that proteokeratan sulfates (PKSs) were associated with collagen fibrils at specific binding sites. In 1991, Funderburgh et al.[2] and Blochberger et al.[3] reported the existence of lumican in connective tissues. Lumican belongs to the family of SLRPs that plays a role in the ECM. The SLRP gene family has expanded in the past decade to encompass 17 genes. Recently, the gene family has been subdivided into 5 classes on several parameters basis, including conservation and homology at the protein and genomic levels, the presence of characteristic N-terminal Cys-rich clusters with defined spacing and chromosomal organization.[4-7] Lumican is classified as class 2 in the SLRP gene family. Lumican has been shown to exist in the connective tissue of many organs, including the cornea, intervertebral disc and tendon, and its behaviour has been studied in several clinical fields.[8-12] Scott[13] have indicated that PKSs play a role in orienting and organizing the collagen fibrils, thus helping to establish and maintain tissue shape. Kafienah et al.[14] reported that lumican plays a role in limiting the growth of type II collagen fibrils during cartilage tissue engineering. Funderburgh et al.[15] revealed that lumican is deeply involved in collagen fibre repair and adjustment, and Saika et al.[16] showed that lumican expressed in injured epithelium may modulate cell behaviours such as adhesion or migration, thus contributing to corneal epithelial wound healing. In addition, Chakravarti et al.[17] revealed the early regulation of collagen structure by lumican during postnatal development of the cornea. Extracellular matrix is composed mainly of collagen and proteoglycan in the articular disc of the TMJ.[18,19] The articular disc lies between the condylar head and the glenoid fossa and helps to absorb force during opening and closing movements and occlusion. Chemical stress due to cytokines and physical stress due to malocclusion have been considered to be major causes of internal derangement (ID) and osteoarthritis (OA) in disorders of the TMJ. It is still unclear what kind of changes happens in the TMJ disc affected by ID and OA and no studies have examined the expression of lumican in the human TMJ disc with ID or OA. Based on the above, we hypothesised that lumican expression was likely to be increased in the deformed discs. Therefore, this study used histology and immunohistochemistry to compare human TMJ discs from normal and diseased individuals.

Materials and Methods

Thirteen human TMJ discs (10 diseased and 3 normal controls) were used in this study. The 10 diseased human TMJ specimens were surgically removed from 10 patients (8 female and 2 male) because of ID with severe pain and dysfunction. All the patients provided their informed consent, and this study was approved by the Ethics Committee of Wakayama Medical University. The patients' age ranged from 20 to 72 years, with a mean age of 43.8 years (Table 1). Magnetic resonance imaging revealed that all patients had anterior disc displacement without reduction. Most of the patients experienced severe pain and all patients experienced disturbances of function without reduction. The patients did not have a history of trauma to the TMJ, and none of them had ankylosis. The three normal TMJ disc specimens were obtained by autopsy from 3 separate female patients (average age 56.7 years) who did not have a clinical history of TMJ disturbances (fresh cadavers); they died of diseases not related to TMJ (a tongue cancer, a gastric cancer and a breast cancer). At the time of autopsy, it was confirmed that the patients did not suffer from anterior disc displacement or deformation. Microscopic examination of haematoxylin-eosin-stained sections did not reveal any pathological changes. All specimens were cut sagittally and immediately fixed overnight in phosphate buffered saline (PBS) solution containing 4% paraformaldehyde, embedded in paraffin wax, and cut into 5 µm-thick sections.
Table 1

Characteristics of patients with temporomandibular disorders included in this study.

Sample no.SexAgeDiagnosisSymptomDisplaementof TMJ disc
(pain)(dysfunction)
1Female24ID and OA+++
2Female52ID and OA+++
3Female20ID and OA+++
4Male72ID and OA++
5Female52ID and OA++
6Male64ID and OA++
7Female34ID and OA++
8Female32ID and OA+++
9Female29ID and OA+++
10Female59ID and OA+++
11Female61Autopsy sample
12Female61Autopsy sample
13Female48Autopsy sample

Immunohistochemical methods

For immunohistochemical staining, the sections were dewaxed in xylene and rehydrated through an alcohol series. Endogenous peroxidase was blocked by immersing the sections in 0.3% H2O2 in methanol for 20 min at room temperature. The specimens were blocked with 3% skimmed milk (in 0.01% Tween-PBS) for 60 min at room temperature and were then stained using a rabbit polyclonal primary antibody against lumican (Wakayama Medical University, Wakayama, Japan) at 4°C for 24 h. The anti-lumican polyclonal antibody was used at a dilution of 1: 800. After washing with PBS, the specimens were treated with the secondary antibody using the EnVision™ + System-HRP Labelled Polymer, Anti-Rabbit (catalogue no. K4003, Dako Corporation, Tokyo, Japan) for 60 min at room temperature. Colour was developed using the Liquid DAB+ Substrate Chromogen System (catalogue no. K3468, Dako Corporation, Tokyo, Japan) followed by counterstaining with Mayer's haematoxylin (No.3000-2 Muto Pure Chemicals Corporation, Tokyo, Japan). For immunohistochemical staining of CD34 and vascular endothelial growth factor (VEGF), anti-human CD34 monoclonal antibody (Nichirei, Tokyo, Japan) and anti- human VEGF polyclonal antibody (Takara, Shiga, Japan) were used at a dilution of 1:5 and 1:3000, respectively. Negative controls were subjected to the same protocol but without the primary antibody.

Histological methods

Histological staining was performed using toluidine blue. Sections were dewaxed in xylene and rehydrated through an alcohol series. After washing with distilled water, sections were stained with 0.05% (w/v) toluidine blue (pH 7.0) for 1 min.

Results

Our findings in the human TMJ discs were as follows. To detect the localization of lumican in the whole human TMJ disc, immunohistochemical analysis was performed. The expression of lumican was detectable in both normal and deformed discs. In normal discs, positive staining of lumican was observed in the connective tissue around the disc and the disc surface, and weak staining for lumican observed inside the disc; whereas in deformed disc the strong expression also spread to the inside of the disc (Figure 1A, C). In both normal and deformed discs, metachromasia was detected by toluidine blue staining (Figure 1B, D).
Figure 1

(A, B, C, D) Lumican expression and toluidine blue staining in the human TMJ disc (scale bar = 100 µm). (A) Lumican expression in the normal disc. (B) Metachromasia in the normal disc. (C) Strong lumican expression in the deformed disc (asterics: uneven or weak expression). (D) Metachromasia in the deformed disc (asterics: positive areas). All specimens are sagittal sections.

(A, B, C, D) Lumican expression and toluidine blue staining in the human TMJ disc (scale bar = 100 µm). (A) Lumican expression in the normal disc. (B) Metachromasia in the normal disc. (C) Strong lumican expression in the deformed disc (asterics: uneven or weak expression). (D) Metachromasia in the deformed disc (asterics: positive areas). All specimens are sagittal sections. In all discs we identified fibroblast-like cells, fibrochondrocytes, without a pericellular halo; and chondrocyte-like cells with rounded nuclei surrounded by a large halo of cytoplasm. In normal discs, the expression of lumican was weak surrounding all the cells (Figure 2A). In deformed discs, lumican was expressed in areas with many fibroblast-like cells (Figure 2B). On the other hand, the expression of lumican was weak surrounding fibrochondrocytes and chondrocyte-like cells (Figure 2C, D).
Figure 2

(A, B, C, D) Immunohistochemical staining of lumican in the TMJ discs (scale bar = 25 µm). (A) The fibroblast-like cells (arrowhead) and the fibrochondrocyte (black arrow), the chondrocyte-like cell (white arrow) in the normal disc (enlargement of circle in Figure 1A). (B) Fibroblast-like cells (arrows) (enlargement of circle in Figure 1C); (C) Fibrochondrocytes (arrows) (enlargement of circle in Figure 1C); (D) Chondrocyte-like cells (arrow) in the deformed disc (enlargement of rectangle in Figure 1C). All specimens are sagital sections.

(A, B, C, D) Immunohistochemical staining of lumican in the TMJ discs (scale bar = 25 µm). (A) The fibroblast-like cells (arrowhead) and the fibrochondrocyte (black arrow), the chondrocyte-like cell (white arrow) in the normal disc (enlargement of circle in Figure 1A). (B) Fibroblast-like cells (arrows) (enlargement of circle in Figure 1C); (C) Fibrochondrocytes (arrows) (enlargement of circle in Figure 1C); (D) Chondrocyte-like cells (arrow) in the deformed disc (enlargement of rectangle in Figure 1C). All specimens are sagital sections. We analyzed the discs following staining with anti-human CD34 monoclonal antibody and anti-human VEGF polyclonal antibody. Positive staining of VEGF and CD34 within the deformed discs was observed (Figure 3A, C), which was not only found in normal discs (Figure 3B, D).
Figure 3

(A, B, C, D) Immunohistochemical staining of CD34 and VEGF in the TMJ discs (scale bar = 50 µm). (A) Weak CD34 is observed sporadically within the normal disc. (B) Strong CD34 expression is observed in the wall of newly formed capillaries while weak expression is seen in the extracellular matrix. (C) VEGF expression was not found in the normal disc. (D) Strong VEGF expression is seen in the wall of newly formed capillaries. All specimens are sagital sections.

(A, B, C, D) Immunohistochemical staining of CD34 and VEGF in the TMJ discs (scale bar = 50 µm). (A) Weak CD34 is observed sporadically within the normal disc. (B) Strong CD34 expression is observed in the wall of newly formed capillaries while weak expression is seen in the extracellular matrix. (C) VEGF expression was not found in the normal disc. (D) Strong VEGF expression is seen in the wall of newly formed capillaries. All specimens are sagital sections.

Discussion

Several recent studies have cast light on the localisation and function of lumican.[8-12] Fibril-associated molecules such as lumican have been implicated in regulating the progression of fibril assembly through a series of steps leading to structurally and mechanically mature fibrils.[20] Electron microscopic investigations of lumican-null mice reveal deregulated growth of collagen fibrils with a significant proportion of abnormally thick fibrils in skin and cornea.[10] Changing patterns of abundance of lumican observed with age suggest that the disc may have different requirements for the composition of its extracellular matrix at different stages of life.[9] Although lumican has been studied in the cornea, tendon and intervertebral disc, very little has been reported on lumican in the TMJ disc. In this study, we focused on the following points; comparison of the positive reactions of toluidine blue, CD34 and VEGF in the deformed discs, confirmation of lumican expression within the TMJ disc and its relationship to disc cells. Firstly, the most interesting finding was identified by toluidine blue staining. Metachromasia could be seen in most areas of both normal and deformed discs. However, areas showing strong metachromasia coincided with weak expression of lumican in all the discs. We found that the positive area of metachromasia in the inside of the deformed disc was uneven and expression of lumican was strong in the areas negative for meta-chromasia. Toluidine blue binds to hyaluronic acid and glycosaminoglycans (GAGs). The large proteoglycans of the TMJ disc are aggrecan,[21-23] which consist of a core protein covalently linked to more than 100 chondroitin sulphate side chains.[24] In corneal lumican, it has been reported that three of five binding sites are acceptors for keratan sulphate.[2,25,26] Thus, we inferred that GAGs-rich ECM decreases due to the deformation of TMJ discs, while GAGs-poor lumican increases with the change of ECM, so that differences in the areas positive for lumican and metachromasia may appear. Secondly, we identified positive expression of CD34 and VEGF in the deformed discs and found that lumican positive areas could be observed not only on the surface but also spread to the inside of the disc. VEGF belongs to the platelet derived growth factor family.[27] Angiogenesis is accompanied by the expression of angiogenic mitogen such as VEGF, which involves the formation of new blood vessels from pre-existing vessels to form a capillary networks.[28,29] CD34 is another transmembrane glycoprotein present on endothelial cells, leukemic cells, and some progenitor cells, which is produced by endothelial cells and associated with angiogenesis.[30,31] Yoshida et al.[31] reported that the presence of CD34 correlates with the process of angiogenesis induced by internal derangement of the TMJ and that new growth of blood capillaries is distributed in the internal derangement of human TMJ discs.[31,32] Leonardi et al. reported that in normal discs, fibroblast-like cells, fibrochondrocytes and chondrocyte-like cells are either unstained or only weakly immunostained by VEGF antibody, while in disc specimens from internal derangement of the TMJ with significant tissue degeneration/regeneration, VEGF is consistently expressed.[33] Thus, we suggest that the spreading expression of lumican to the inside of the disc might be affected by inflammatory cytokines from blood capillaries. The human TMJ disc has been said to contain fibroblast-like cells, fibrochondrocytes and chondrocyte-like cells.[34] We confirmed that the large number of fibroblast-like cells co-localise with lumican expression in our specimens. In contrast, little lumican expression was observed in the vicinity of fibrochondrocytes and chondrocyte-like cells. In the current study lumican up-regulates before epithelial-mesenchymal transition (EMT) of the lens epithelial cells, which is characterized by a fibroblast-like morphology and by expression of α-smooth muscle actin (αSMA) and collagen type I.[35,36] It has been suggested that the up-regulation of αSMA immunolabelling is associated with histopathological findings and in particular with an attempt for disc healing and plays an important role in the favourable evolution of a pathological phenomenon, such as in the case of deformed disc.[37] Vij et al. revealed that Lumcan (−/−) mouse embryonic fibroblasts (MEF), compared to their wild type counterparts, display increased rates of proliferation and decreased apoptosis, and lumican appears to regulate these cellular functions by modulating specific cell growth and apoptosis mediators.[38] For the reasons mentioned above, we suggested that expression of lumican may relate to an increase and a decrease of fibroblast-like cell in the TMJ disc and fibrosis of the deformed disc. In summary, lumican expression may play a key role in the generation of a new collagen network by fibroblast-like cells. On the basis of these results, further research should be conducted to understand the involvement of mechanical stress acting on disc cells and proteoglycans in the TMJ disc and would be necessary to investigate a role for lumican in the regulation of collagen assembly using lumican-null mice.[36,39]
  39 in total

1.  Immunolocalization of vimentin and alpha-smooth muscle actin in dysfunctional human temporomandibular joint disc samples.

Authors:  R Leonardi; L Villari; C Piacentini; G Bernasconi; S Travali; C Caltabiano
Journal:  J Oral Rehabil       Date:  2002-03       Impact factor: 3.837

2.  Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family.

Authors:  S P Henry; M Takanosu; T C Boyd; P M Mayne; H Eberspaecher; W Zhou; B de Crombrugghe; M Hook; R Mayne
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

3.  Role of lumican in the corneal epithelium during wound healing.

Authors:  S Saika; A Shiraishi; C Y Liu; J L Funderburgh; C W Kao; R L Converse; W W Kao
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue.

Authors:  Koichi Wauke; Masakazu Nagashima; Toshiyuki Ishiwata; Goro Asano; Shinichi Yoshino
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

5.  Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition.

Authors:  Shizuya Saika; Takeshi Miyamoto; Sai-ichi Tanaka; Takeshi Tanaka; Iku Ishida; Yoshitaka Ohnishi; Akira Ooshima; Toshiyuki Ishiwata; Goro Asano; Tai-ichiro Chikama; Atsushi Shiraishi; Chia-Yang Liu; Candace W-C Kao; Winston W-Y Kao
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

6.  Type II collagen and aggrecan mRNA expression by in situ hybridization in rabbit temporomandibular joint posterior attachment following disc displacement.

Authors:  Zhiyuan Gu; Jianying Feng; Takanori Shibata; Ji'an Hu; Zhenkang Zhang
Journal:  Arch Oral Biol       Date:  2003-01       Impact factor: 2.633

7.  Expression of vascular endothelial growth factor in human dysfunctional temporomandibular joint discs.

Authors:  R Leonardi; L Lo Muzio; G Bernasconi; C Caltabiano; C Piacentini; M Caltabiano
Journal:  Arch Oral Biol       Date:  2003-03       Impact factor: 2.633

8.  A histochemical survey of the human temporomandibular joint disc of patients with internal derangement without reduction.

Authors:  Rosalia Leonardi; Carla Loreto; Ersilia Barbato; Antonella Polimeni; Rosario Caltabiano; Lorenzo Lo Muzio
Journal:  J Craniofac Surg       Date:  2007-11       Impact factor: 1.046

9.  Lumican is a major proteoglycan component of the bone matrix.

Authors:  Afshin Raouf; Bernhard Ganss; Chris McMahon; Calvin Vary; Peter J Roughley; Arun Seth
Journal:  Matrix Biol       Date:  2002-06       Impact factor: 11.583

10.  Fibromodulin-null murine knee joints display increased incidences of osteoarthritis and alterations in tissue biochemistry.

Authors:  M R Gill; A Oldberg; F P Reinholt
Journal:  Osteoarthritis Cartilage       Date:  2002-10       Impact factor: 6.576

View more
  14 in total

1.  Low-level laser therapy stimulates tissue repair and reduces the extracellular matrix degradation in rats with induced arthritis in the temporomandibular joint.

Authors:  George Azevedo Lemos; Renato Rissi; Ivan Luiz de Souza Pires; Letícia Prado de Oliveira; Andrea Aparecida de Aro; Edson Rosa Pimentel; Evanisi Teresa Palomari
Journal:  Lasers Med Sci       Date:  2016-05-04       Impact factor: 3.161

2.  Lubricin is Required for the Structural Integrity and Post-natal Maintenance of TMJ.

Authors:  E Koyama; C Saunders; I Salhab; R S Decker; I Chen; H Um; M Pacifici; H D Nah
Journal:  J Dent Res       Date:  2014-05-16       Impact factor: 6.116

3.  Effect of alendronate on endochondral ossification in mandibular condyles of growing rats.

Authors:  V Bradaschia-Correa; F A C Barrence; L B Ferreira; L F Massa; V E Arana-Chavez
Journal:  Eur J Histochem       Date:  2012-05-25       Impact factor: 3.188

4.  Increased risk of temporomandibular joint closed lock: a case-control study of ANKH polymorphisms.

Authors:  Boyen Huang; Katsu Takahashi; Tomoko Sakata; Honoka Kiso; Manabu Sugai; Kazuma Fujimura; Akira Shimizu; Shinji Kosugi; Tosiya Sato; Kazuhisa Bessho
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

5.  Histochemistry through the years, browsing a long-established journal: novelties in traditional subjects.

Authors:  C Pellicciari
Journal:  Eur J Histochem       Date:  2010-12-16       Impact factor: 3.188

6.  Expression of hyaluronan synthase 3 in deformed human temporomandibular joint discs: in vivo and in vitro studies.

Authors:  T Matsumoto; M Inayama; I Tojyo; N Kiga; S Fujita
Journal:  Eur J Histochem       Date:  2010-12-15       Impact factor: 3.188

7.  Expression of lumican and fibromodulin following interleukin-1 beta stimulation of disc cells of the human temporomandibular joint.

Authors:  N Kiga; I Tojyo; T Matsumoto; Y Hiraishi; Y Shinohara; S Makino; S Fujita
Journal:  Eur J Histochem       Date:  2011       Impact factor: 3.188

8.  Immunohistochemical expression of types I and III collagen antibodies in the temporomandibular joint disc of human foetuses.

Authors:  L O C de Moraes; F R Lodi; T S Gomes; S R Marques; C T F Oshima; C L P Lancellotti; J F Rodríguez-Vázquez; J R Mérida-Velasco; L G Alonso
Journal:  Eur J Histochem       Date:  2011-08-27       Impact factor: 3.188

9.  Identifying pathological biomarkers: histochemistry still ranks high in the omics era.

Authors:  C Pellicciari; M Malatesta
Journal:  Eur J Histochem       Date:  2011-12-07       Impact factor: 3.188

10.  On the future contents of a small journal of histochemistry.

Authors:  C Pellicciari
Journal:  Eur J Histochem       Date:  2012-12-10       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.